W e thank Lauren Mokry and Brent Richards for their letter regarding our article BVitamin D: A Narrative Review Examining the Evidence for Ten Beliefs. ^1 We would like to begin by clarifying a few issues regarding our paper that seem to have been misunderstood. First, our paper is not a systematic review. It is a thorough narrative review that generally follows the principles of a systematic review but, as explained in the title, is a narrative review. Second, as outlined on the first page of the paper, observational studies were discussed to clarify the origin and support for a belief in the benefits of vitamin D supplementation for a specific health outcome. We used only the highest level evidence, randomized controlled trials (RCT) and systematic reviews/metaanalysis of RCTs, to determine whether vitamin D supplementation truly influences clinical outcomes. Third, in addition to fracture prevention, we suggested that vitamin D supplementation may reduce falls and have a small impact on mortality.
W e thank Lauren Mokry and Brent Richards for their letter regarding our article BVitamin D: A Narrative Review Examining the Evidence for Ten Beliefs. ^1 We would like to begin by clarifying a few issues regarding our paper that seem to have been misunderstood. First, our paper is not a systematic review. It is a thorough narrative review that generally follows the principles of a systematic review but, as explained in the title, is a narrative review. Second, as outlined on the first page of the paper, observational studies were discussed to clarify the origin and support for a belief in the benefits of vitamin D supplementation for a specific health outcome. We used only the highest level evidence, randomized controlled trials (RCT) and systematic reviews/metaanalysis of RCTs, to determine whether vitamin D supplementation truly influences clinical outcomes. Third, in addition to fracture prevention, we suggested that vitamin D supplementation may reduce falls and have a small impact on mortality.
Mokry and Richards suggest that vitamin D is off-patent so RCTs are unlikely, but as our review shows, some metaanalyses included 95,000 randomized patients so RCTs do get done. Still, multiple sclerosis (MS) is relatively rare, and a prevention RCT would likely require a very large number of randomized patients. Mendelian randomization is one way to examine potential cause-and-effect relations in a none x p e r i m e n t a l w a y. H o w e v e r, d e s p i t e t h e t e r m Brandomization,^this methodology is still observational with some of the typical risks of bias seen in observational studies, and they have been shown to provide findings discordant with RCT evidence. 2 The Mendelian randomization paper of Mokry and colleague does support a potential causal role of vitamin D in the etiology of MS. While intriguing, we strongly agree with the authors' own conclusions: BWhether vitamin D sufficiency can delay, or prevent, MS onset merits further investigation in long-term randomized controlled trials.^3 We believe before clinicians recommend wholesale vitamin D screening and treatment for any condition, the evidence for benefit should be based on findings from RCTs.
